Biomarkers in the diagnosis, management and prognosis of cardiovascular disease

Useful and feasible dynamic biomarkers for the diagnosis, management, and prognosis of cardiovascular diseases (CVD) represent an important and emerging tool in the field of medicine. Likewise, knowledge of new biomarkers related to CVD may provide clinicians with more potential tools to quickly identify patients at higher risk of CVD, attenuate its occurrence, improve its management, and decrease the risk of adverse events. In this special issue, the reader will find state-of-the art contributions involving both classic and novel biomarkers of CVD, specifically in myocardial infarction (MI), coronary artery disease (CAD), heart failure (HF), and hypertrophic cardiomyopathy (HCM).